Russian version of the neurogenic bladder symptom score (NBSS)

Филиппова, Е. С.; Баженов, И. В.; Volkova, L. I.; Moskvina, Ekaterina Y.; Turova, E L; Popova, Yulia V.

doi:10.18565/urology.2018.6.5-13

Cited by 14 publications

(11 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Total scores can range from 0 (no symptoms at all) to 74 (maximum symptoms). Validated translations into Brazilian Portuguese [ 17 ], Italian [ 18 ], and Russian [ 19 ] have been published.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Lower Urinary Tract Dysfunction Impact on Quality of Life in Multiple Sclerosis Patients: Russian Translation and Validation of SF-Qualiveen

Филиппова

Баженов

Ziryanov

et al. 2020

Multiple Sclerosis International

View full text Add to dashboard Cite

The Short Form Qualiveen (SF-Qualiveen) is an 8-item version of the Qualiveen questionnaire used to evaluate the impact of urinary symptoms on the quality of life in patients with urological dysfunction due to neurological disorders. The questionnaire was never available in the Russian language before. The study is aimed at providing the translation, cultural adaptation, and validation of a Russian version of the SF-Qualiveen for the use in patients with multiple sclerosis (MS). Materials and Methods. The original English language version of the SF-Qualiveen was translated into Russian according to the cultural and linguistic adaptation algorithm. The participants (50 MS patients with neurogenic bladder and 10 relatively healthy volunteers) filled out the finalized Russian version of the SF-Qualiveen and the Neurogenic Bladder Symptom Score (NBSS) twice, 2 weeks apart. The data obtained was used to determine the internal consistency (Cronbach’s alpha), external validity (the Spearman correlation), and test-retest reliability (intraclass correlation coefficient (ICC)) of the questionnaire. Results. The mean SF-Qualiveen total score was 2.51±0.79 in patients with a neurogenic bladder and 0.1±0.02 in the control group (p<0.001). Cronbach’s alpha exceeded 0.9 indicating an excellent internal consistency of the questionnaire. The retest did not reveal any significant differences between the findings. The test-retest reliability was good for all items and domains (ICC 0.81-0.89). The total score demonstrated the highest ICC (0.89). The external validity was verified by a strong correlation demonstrated between the SF-Qualiveen and NBSS scores. Conclusions. The Russian SF-Qualiveen questionnaire is a reliable, valid, and consistent tool for the assessment of a urinary disorder impact on the quality of life in patients with MS.

show abstract

Section: Introductionmentioning

confidence: 99%

Evaluation of Lower Urinary Tract Dysfunction Impact on Quality of Life in Multiple Sclerosis Patients: Russian Translation and Validation of SF-Qualiveen

Филиппова

Баженов

Ziryanov

et al. 2020

Multiple Sclerosis International

View full text Add to dashboard Cite

show abstract

“…It is higher than in other adaptations. [22][23][24] Pearson's correlation was moderate (0.57), lower than in the original study, 12 which can be explained by the different objectives of the two questionnaires used: Qualiveen-SF was created for the assessment of QoL solely, and NBSS for both urinary symptoms and QoL, although only the last question was focused on QoL (Q24). As a quality test, we compared Q24 to the total score of the NBSS, and we observed that the total score increases proportionally to the perceived bladder dysfunction.…”

Section: Discussionmentioning

confidence: 65%

“…12 We acknowledge that there are many questionnaires that include bowel and sexual dysfunction items, nevertheless we chose the NBSS because it has been applied in many neurologic diseases such as MS, 18 SCI, 19 cerebral palsy, 15 and spina bifida, 20 and it also has proven responsiveness to positive clinical change. 21 The NBSS has been validated previously in Portuguese, 17 Greek, 22 Russian, 23 Turkish, 24 and Polish. 25 This study reflects the effort of three Spanishspeaking countries, working together to achieve homogeneity and to prove the feasibility of the use of this questionnaire in the Spanish-speaking population.…”

Section: Discussionmentioning

confidence: 99%

“…We acknowledge that there are many questionnaires that include bowel and sexual dysfunction items, nevertheless we chose the NBSS because it has been applied in many neurologic diseases such as MS, 18 SCI, 19 cerebral palsy, 15 and spina bifida, 20 and it also has proven responsiveness to positive clinical change 21 . The NBSS has been validated previously in Portuguese, 17 Greek, 22 Russian, 23 Turkish, 24 and Polish 25 …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Cross‐cultural adaptation and validation of the neurogenic bladder symptom score for Spanish speakers

Moreno‐Palacios

Castro‐Nuñez

Padilla‐Fernández

et al. 2021

Neurourology and Urodynamics

View full text Add to dashboard Cite

Aim: To perform a cross-cultural adaptation and validation of the Neurogenic Bladder Symptom Score (NBSS) to Spanish in patients with neurogenic lower urinary tract dysfunction.Materials and Methods: The questionnaire was culturally adapted according to international guidelines. It was applied, twice in a range of 14-28 days.Psychometric properties were tested such as content validity, construct validity, internal consistency, and test-retest reliability.

show abstract

“…Treatment and control group patients were asked to fill out the Neurogenic Bladder Symptom Score (NBSS) 8 every time at the measuring points. All the patients from the study group underwent general clinical blood and urine tests, urinary tract ultrasonography with postvoid residual measurement, uroflowmetry, and invasive urodynamic study (UDS), included filling cystometry (25 ml/min) and pressure‐flow study according to the good urodynamic practices 9 .…”

Section: Methodsmentioning

confidence: 99%

Impact of intradetrusor botulinum toxin A injections on serum and urinary concentrations of nerve growth factor and brain‐derived neurotrophic factor in patients with multiple sclerosis and neurogenic detrusor overactivity

Филиппова

Баженов

Ziryanov

et al. 2020

Neurourology and Urodynamics

View full text Add to dashboard Cite

Aims: To evaluate the practical relevance of changes in serum and urinary neurotrophins levels in patients with multiple sclerosis (MS) and neurogenic lower urinary tract dysfunction (NLUTD) after intradetrusor injections of botulinum toxin A (BoNTA). Methods: The study included 36 patients with MS and NLUTD and 20 controls. The patients with NLUTD received intradetrusor injection of BoNTA (200 U). The nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) levels were measured in serum and urine at baseline and then at 1, 3, and 6 months by enzyme-linked immunosorbent assay. Urinary NGF and BDNF were normalized to creatinine (NGF/Cr, BDNF/Cr). Patients' assessment included urodynamic examination and Neurogenic Bladder Symptom Score (NBSS). Results: After BoNTA injections, no significant changes were observed in the serum NGF and BDNF or the urinary BDNF/Cr. The urinary NGF/Cr was significantly higher in MS patients (1.23 ± 0.34) at baseline compared with controls (0.084 ± 0.02; p = .021). The urinary NGF/Cr decreased to 0.51 ± 0.12 (p = .001) and 0.53 ± 0.32 (p = .005) at 1 and 3 months, increasing to 1.12 ± 0.49 (p = .003) at 6 months. The urinary NGF/Cr level at baseline demonstrated a low diagnostic accuracy in predicting a better response to the BoNTA treatment (area under the curve = 0.661; p = .047) and no correlation with the urodynamic parameters. Conclusions: The urinary NGF/Cr at baseline or its reduction at the first month following treatment does not serve as a predictor for the response to the BoNTA injections or for urodynamic changes.

show abstract

Russian version of the neurogenic bladder symptom score (NBSS)

Cited by 14 publications

References 0 publications

Evaluation of Lower Urinary Tract Dysfunction Impact on Quality of Life in Multiple Sclerosis Patients: Russian Translation and Validation of SF-Qualiveen

Evaluation of Lower Urinary Tract Dysfunction Impact on Quality of Life in Multiple Sclerosis Patients: Russian Translation and Validation of SF-Qualiveen

Cross‐cultural adaptation and validation of the neurogenic bladder symptom score for Spanish speakers

Impact of intradetrusor botulinum toxin A injections on serum and urinary concentrations of nerve growth factor and brain‐derived neurotrophic factor in patients with multiple sclerosis and neurogenic detrusor overactivity

Contact Info

Product

Resources

About